Nektar Therapeutics (NKTR) Q4 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.25
-0.23
-0.2
-0.18

Details

Expected EPS
-0.199013
Actual EPS
-0.18
Surprise EPS
0.02
Surprise Percent
+9.55%

Description

⁨Nektar Therapeutics⁩ (⁦NKTR⁩) has reported earnings of ⁦-0.18⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts